Exploring the Trade-offs Between Speech and Gait in Parkinson’s Disease
Objective: The goal of the study was to explore speech and gait performance trade-off when individuals with Parkinson’s disease (PD) engaged in concurrent speaking and…Parkinson’s Disease (PD) and Type II Diabetes (T2DM): Risk and Progression
Objective: To test whether PD risk is greater in those with a prior diagnosis of T2DM, and whether T2DM is associated with faster PD clinical…Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease
Objective: To integrate [18F]-FDG PET (fPET) and objective motor performance to unravel metabolic networks associated with deep brain stimulation (DBS) outcomes in Parkinson’s disease (PD).…Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses
Objective: This large-scale case-control study using network pharmacology and molecular docking, aimed to identify dietary and environmental risk factors of Parkinson’s disease (PD). Background: PD…Towards automated deep brain stimulation programming using neurophysiology and artificial intelligence
Objective: To develop a machine learning (ML) algorithm capable of predicting the optimal deep brain stimulation (DBS) contact based on neurophysiology. Background: DBS is an…Wearable-based Virtual Motor Exam enables remote tracking of motor symptom progression in early-stage Parkinson’s disease
Objective: To evaluate the ability of smartwatch-based measures of tremor, bradykinesia and gait to capture Parkinson’s disease (PD) progression. Background: Wearable sensors enable remote, objective,…Effectiveness of Interactive Rhythmic Stimulation on Gait Improvement in Elderly Patients: An R and Python Perspective
Objective: To evaluate the effectiveness of interactive rhythmic stimulation on gait improvement in elderly patients using data-driven insights from R and Python-based analyses. Background: Gait…Case report and Literature Review on Atypical Parkinson’s Disease
Objective: Atypical parkinsonism is classified as a subgroup of Progressive neurodegenerative diseases, characterized by symptoms of Parkinson's disease. Background: Progressive supra nuclear palsy of the…Empathy in Action A Sensory Experience for Healthcare Providers
Objective: Evaluate the impact of a multisensory, hands-on experience designed to simulate the motor and non-motor symptoms of Parkinson’s disease (PD) on healthcare providers’ (HCPs)…A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease
Objective: To evaluate the efficacy and safety of NDM-101 as an adjunct to levodopa in reducing OFF-time, improving motor function, and maintaining quality of life…
- 1
- 2
- 3
- …
- 436
- Next Page »